Avulux, the maker of the only clinically proven migraine and light sensitivity lenses, and PECAA (Professional Eye Care Associates of America) are pleased to announce a partnership that now makes Avulux technology available to all PECAA Max members. This arrangement follows record growth for Avulux in 2024, including a pilot program in which PECAA members found great value in the lenses.
“We couldn’t be more excited to deepen our partnership with PECAA,” said Derek Johnson, Director of Strategic Accounts at Avulux. “PECAA is an incredible advocate for independent eye care providers, and we’re honored to support their mission by offering a solution that enhances patient care while creating new growth opportunities for practices.”
With over one billion people worldwide affected by migraine—and over 90% of them experiencing light sensitivity—Avulux provides eye care providers with a unique lens that filters the harmful light linked to light sensitivity and migraine to address a widespread disease.
“Avulux is a promising addition to PECAA member practices, especially with its evidence-based studies and subsequent grant of a U.S. Food and Drug Administration pathway to market using a migraine claim,” says PECAA member and Avulux provider Dr. Brenda Montecalvo. “In my own practice, we trial it with patients who hadn’t found solutions for their migraines. For specific groups, we saw that Avulux reduced their visual stress. That, in turn, helped resolve or relieve their migraine symptoms.”
Avulux, now bringing its science-backed lens technology and dedicated support directly to PECAA Max members, remains committed to helping private practices thrive through personalized training, marketing assistance, and expert guidance.
PECAA President Jonathan Worrall said, “Our focus is on helping private practice doctors remain profitable and ahead of the curve in a diverse eye care landscape. Avulux’s cutting-edge technology aligns with that goal by providing PECAA Max members with an opportunity to bring needed relief to a large portion of their patient base while presenting a new revenue stream.”
To learn more about Avulux, tune into PECAA’s latest Practice Advantage Podcast episode on The Future of Eye Care in which Johnson shares powerful insights into how Avulux lenses are empowering eye care providers and making a meaningful impact on patients’ lives.
PECAA Max members can visit PECAA.com to leverage the Avulux partnership and discover the full benefits of membership, including peer networking opportunities, practice management services, educational resources, and exclusive vendor programs.